N/A N=108 Next Generation Cataract Surgery Study
Cataract
Primary: Percent of 'Yes' Responses to the Binary Question: "Did UNITY VCS Anterior Segment Surgical Functionality Perform Per the Intended Use as Defined in Protocol Section…
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=188 Implementing a Combination of Clinical Parameters, Biomarkers and SoCs for the Etiology Diagnoses of Pneumonia in Pediatric Patients
Pneumonia
Primary: White Blood Cells and Absolute Neutrophil Count Cut-off Levels for Distinguishing of Viral and Bacterial/Mixed Pathogens — 12.2; 6.15 10^3 cells/microliter — p=0.0048
N/A N=72 The Elders' Resilience Curriculum
Suicidal Ideation
Primary: Change in Reasons for Life as Assessed by the Reasons for Life Scale — 2.36 score on a scale — p=0.0006
Phase 4 N=110 Postpartum ASA and NT-proBNP
Blood Pressure
Primary: NT-proBNP Levels at 4-6 Weeks Postpartum — 36.5; 39.5 pg/mL — p=0.49
N/A N=41 Heat Therapy Versus Exercise Training in Hypertension
Hypertension · Cardiovascular Diseases · Arterial Hypertension
Primary: Blood Pressure Reduction: Change in Systolic and Diastolic Ambulatory Blood Pressure (mmHg) After 30 Sessions of Intervention — -1; 0; 0; 1 mmHg
N/A N=39 cTBS/fMRI Study of Hierarchical Control in the PFC
Transcranial Magnetic Stimulation
Primary: PFC-PPC Effective Connectivity — 0.3646; 0.3756; 0.3425; 0.4519 Hertz — p=0.5736
N/A N=64 Trial of Bilateral Sagittal Split Osteotomy Induced Paresthesia Using Ultrasonic vs. Reciprocating Saw Instrumentation
Surgical Complication · Paresthesia · Fracture
Primary: Postoperative Hypoesthesia Experienced at 3months — 8; 3 Left or Right Chin Area
N/A N=2,207 A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Arthritis, Rheumatoid · Colitis, Ulcerative · Crohn Disease
Primary: Incidence Rate of Serious Infections — 0.06; 0.09; 0.22; 0.09 serious infections per 1 person-year
N/A N=62 Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds
Nasolabial Fold, Hypoplastic
Primary: NLF-SRS Grade of Nasolabial Folds Change — -1.50 score on a scale
N/A N=127 Post-op Crowd Sourcing Health Data Via Text-messaging
Orthopedic Surgery · Opioid Use · Acute Injuries Knee
Primary: Number of Opioid Tablets Taken Within 28 Days — 8.05; 11.55 number of pills taken
Phase 2 N=20 A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)
Covid19
Primary: Respiratory Failure-free Survival in Participants With Moderate-severe COVID-19 Who Are Treated With ATI-450 — 50; 60 percentage of total patients
N/A N=318 Pittsburgh and Rural Area High School Tobacco Prevention
Adolescent Behavior · Tobacco Use · E-Cig Use
Primary: Percentage of Eligible 9th Grade Students Recruited to Participate in the Study — 158; 160 Participants
Phase 2 N=6 Propranolol for Challenging Behaviors in Autism
Autism Spectrum Disorder · Developmental Disability · Aggression
Primary: Aberrant Behavior Checklist--Community (ABC-C) Irritability Subscale Scores — 14.0; 18.50 score on a scale — p=0.12
N/A N=319 A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes
Type 2 Diabetes Treated With Insulin
Primary: HbA1c — 8.2; 8.1; 7.3; 7.7 percentage of glycated hemoglobin — p=<0.001
N/A N=34 Evaluation of Acuvue Oasys 1-Day Contact Lenses in New Wearers
Visual Acuity
Primary: Incidence (Percentage) of Eyes With Grade 3 or 4 Slit Lamp Findings Related to the Study Lenses — 0 Percentage